Delivering mitochondrial health
In late June, Abliva will attend the US patient organization UMDF’s Mitochondrial Medicine Conference in Cleveland, Ohio. "Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial […]
In September, Abliva will attend the Nordic Life Science Days (NLS days) in Malmö, Sweden. Ablia's CEO, Ellen Donnelly, will be presenting the company at 11:00 a.m. CET on September […]
In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon. Abliva's CMO, Magnus Hansson will attend the […]
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow […]
Abliva will attend the CNS Summit 2024, taking place November 10-13 at Encore Boston Harbor. The company's CEO, Ellen Donnelly, has organized and will join the spotlight panel discussion: Medicines […]
In mid-November, Abliva will attend LSX's Investival Showcase in London, UK. Abliva's CEO, Ellen Donnelly, will be presenting the company at 11:30 a.m. GMT. The Investival Showcase is a Biotech, […]
In late November, Abliva will participate in BioStock's Life Science Summit in Lund, Sweden. CMO, Magnus Hansson, will be presenting the company at 15:10 CET on November 21. For more […]
